iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE – Get Free Report) shares saw strong trading volume on Friday. 498,149 shares were traded during trading, an increase of 217% from the previous session’s volume of 157,136 shares. The stock last traded at $98.4180 and had previously closed at $99.00.
iShares U.S. Pharmaceuticals ETF Price Performance
The firm has a market cap of $1.60 billion, a price-to-earnings ratio of 17.75 and a beta of 0.49. The firm has a fifty day simple moving average of $103.16 and a two-hundred day simple moving average of $95.57.
Institutional Investors Weigh In On iShares U.S. Pharmaceuticals ETF
Institutional investors and hedge funds have recently made changes to their positions in the stock. Root Financial Partners LLC lifted its position in iShares U.S. Pharmaceuticals ETF by 88.9% during the 4th quarter. Root Financial Partners LLC now owns 510 shares of the company’s stock worth $43,000 after acquiring an additional 240 shares during the period. Trust Co. of Vermont acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF during the second quarter worth about $60,000. Integrated Wealth Concepts LLC purchased a new stake in iShares U.S. Pharmaceuticals ETF in the second quarter valued at approximately $75,000. Global Retirement Partners LLC boosted its position in iShares U.S. Pharmaceuticals ETF by 194.7% in the fourth quarter. Global Retirement Partners LLC now owns 837 shares of the company’s stock valued at $71,000 after buying an additional 553 shares during the last quarter. Finally, Sunbelt Securities Inc. increased its holdings in iShares U.S. Pharmaceuticals ETF by 14.3% in the 1st quarter. Sunbelt Securities Inc. now owns 960 shares of the company’s stock worth $83,000 after buying an additional 120 shares during the period.
About iShares U.S. Pharmaceuticals ETF
iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.
See Also
- Five stocks we like better than iShares U.S. Pharmaceuticals ETF
- AST SpaceMobile’s BlueBird Progress Comes With Several Risks Still Unresolved
- Time to Nibble on MCD Stock After it Enters Oversold Territory?
- McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal Upside
- Corning and AT&T’s $3 Billion Fiber Deal Reveals Where AI Spending Goes Next
Receive News & Ratings for iShares U.S. Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares U.S. Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.
